Genpact Total Revenue vs Income Tax Expense Analysis
G Stock | USD 30.90 0.21 0.68% |
Genpact financial indicator trend analysis is much more than just examining Genpact Limited latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Genpact Limited is a good investment. Please check the relationship between Genpact Total Revenue and its Income Tax Expense accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Total Revenue vs Income Tax Expense
Total Revenue vs Income Tax Expense Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Genpact Limited Total Revenue account and Income Tax Expense. At this time, the significance of the direction appears to have weak relationship.
The correlation between Genpact's Total Revenue and Income Tax Expense is 0.3. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of Genpact Limited, assuming nothing else is changed. The correlation between historical values of Genpact's Total Revenue and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of Genpact Limited are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Total Revenue i.e., Genpact's Total Revenue and Income Tax Expense go up and down completely randomly.
Correlation Coefficient | 0.3 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Total Revenue
Total revenue comprises all receipts Genpact Limited generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Income Tax Expense
Most indicators from Genpact's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genpact Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. The Genpact's current Sales General And Administrative To Revenue is estimated to increase to 0.26, while Selling General Administrative is projected to decrease to roughly 576 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.4B | 1.5B | 1.6B | 902.8M | Total Revenue | 4.0B | 4.4B | 4.5B | 2.4B |
Genpact fundamental ratios Correlations
Click cells to compare fundamentals
Genpact Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Genpact fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 4.5B | 4.9B | 5.0B | 4.6B | 4.8B | 3.1B | |
Total Stockholder Equity | 1.7B | 1.8B | 1.9B | 1.8B | 2.2B | 1.4B | |
Net Debt | 1.3B | 1.3B | 1.1B | 1.0B | 919.3M | 965.3M | |
Retained Earnings | 648.7M | 741.7M | 732.5M | 780.0M | 1.1B | 1.1B | |
Cash | 467.1M | 680.4M | 899.5M | 646.8M | 583.7M | 449.6M | |
Other Assets | 478.8M | 961.1M | 667.3M | 439.6M | 1.0 | 0.95 | |
Cash And Short Term Investments | 467.1M | 680.4M | 899.5M | 646.8M | 583.7M | 472.7M | |
Common Stock Shares Outstanding | 195.2M | 195.8M | 193.0M | 188.1M | 185.1M | 200.1M | |
Liabilities And Stockholders Equity | 4.5B | 4.9B | 5.0B | 4.6B | 4.8B | 3.1B | |
Other Stockholder Equity | 1.6B | 1.6B | 1.7B | 1.8B | 1.9B | 1.3B | |
Total Liab | 2.8B | 3.0B | 3.1B | 2.8B | 2.6B | 1.6B | |
Total Current Assets | 1.6B | 1.7B | 1.9B | 1.8B | 1.9B | 1.2B | |
Short Long Term Debt Total | 1.8B | 1.9B | 2.0B | 1.7B | 1.5B | 950.6M | |
Other Current Liab | 629.7M | 694.0M | 678.2M | 675.7M | 674.4M | 470.9M | |
Total Current Liabilities | 910.2M | 1.2B | 1.3B | 1.1B | 1.3B | 758.6M | |
Other Liab | 192.2M | 239.9M | 249.2M | 208.0M | 239.2M | 192.5M | |
Property Plant And Equipment Net | 584.9M | 535.8M | 485.7M | 379.1M | 393.7M | 285.6M | |
Current Deferred Revenue | 97.3M | 154.7M | 160.6M | 160.6M | 112.4M | 77.9M | |
Accounts Payable | 22.0M | 13.9M | 25.0M | 35.8M | 27.7M | 20.2M | |
Non Current Assets Total | 2.9B | 3.1B | 3.1B | 2.8B | 2.9B | 1.9B | |
Non Currrent Assets Other | 217.1M | 323.8M | 322.2M | 450.5M | 379.6M | 213.0M | |
Long Term Debt | 1.3B | 1.3B | 1.3B | 1.2B | 824.7M | 690.1M | |
Net Receivables | 914.3M | 881.0M | 887.7M | 994.8M | 1.1B | 613.1M | |
Good Will | 1.6B | 1.7B | 1.7B | 1.7B | 1.7B | 1.2B | |
Common Stock Total Equity | 1.9M | 1.9M | 1.8M | 1.8M | 1.6M | 2.6M | |
Non Current Liabilities Total | 1.9B | 1.8B | 1.8B | 1.7B | 1.2B | 966.8M | |
Inventory | 121.2M | 150.1M | 103.7M | 1.0 | 1.15 | 1.09 | |
Other Current Assets | 49.2M | 37.3M | 30.7M | 138.0M | 169.0M | 177.5M | |
Property Plant And Equipment Gross | 618.4M | 585.9M | 485.7M | 379.1M | 984.1M | 1.0B | |
Accumulated Other Comprehensive Income | (532.0M) | (545.3M) | (554.4M) | (733.1M) | (722.6M) | (686.4M) | |
Short Term Debt | 161.2M | 340.0M | 445.0M | 231.2M | 503.4M | 528.6M | |
Intangible Assets | 230.9M | 236.7M | 169.6M | 89.7M | 53.0M | 50.4M | |
Common Stock | 1.9M | 1.9M | 1.8M | 1.8M | 1.8M | 2.5M | |
Property Plant Equipment | 254.0M | 231.1M | 485.7M | 379.1M | 436.0M | 238.5M | |
Short Term Investments | 1.8M | 8.8M | 5.8M | 5.4M | 4.4M | 4.2M | |
Net Tangible Assets | (116.2M) | (98.2M) | (3.5M) | 52.2M | 47.0M | 44.7M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genpact Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Genpact Limited information on this page should be used as a complementary analysis to other Genpact's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Genpact Stock analysis
When running Genpact's price analysis, check to measure Genpact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genpact is operating at the current time. Most of Genpact's value examination focuses on studying past and present price action to predict the probability of Genpact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genpact's price. Additionally, you may evaluate how the addition of Genpact to your portfolios can decrease your overall portfolio volatility.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Transaction History View history of all your transactions and understand their impact on performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Genpact's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.311 | Dividend Share 0.55 | Earnings Share 3.41 | Revenue Per Share 24.552 | Quarterly Revenue Growth 0.04 |
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.